echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The White House will nominate the new director of FDA, Tian Shili biology, for IPO in Hong Kong

    The White House will nominate the new director of FDA, Tian Shili biology, for IPO in Hong Kong

    • Last Update: 2019-10-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    (2019 / 10 / 25) investigris bio's IPO capital in Hong Kong helps long-term development; policy increases add new ways for commercial production of ADC drugs in cdmo industry; AstraZeneca abandons the cooperation with Huang pharmaceutical in the development of savilitinib phase 3 renal cancer research; Bai Aotai is about to take the first imitation of adamumumab Letting go is also a kind of accomplishment

    ADC drug development is very difficult


    Do they have secrets? There seems to be no similar enterprise in China

    Big data has been broken

    Another bald head..

    The HKEx has been busy recently.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.